Onconova Therapeutics Inc. (ONTX) Sees Large Volume Increase
Shares of Onconova Therapeutics Inc. (NASDAQ:ONTX) saw unusually-strong trading volume on Tuesday . Approximately 143,823 shares traded hands during mid-day trading, an increase of 17% from the previous session’s volume of 122,454 shares.The stock last traded at $3.56 and had previously closed at $3.70.
Separately, Maxim Group set a $6.00 price objective on shares of Onconova Therapeutics and gave the company a “buy” rating in a report on Thursday, August 11th. One analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $24.74.
The firm has a 50 day moving average price of $4.33 and a 200 day moving average price of $4.81. The stock’s market capitalization is $9.70 million.
Onconova Therapeutics (NASDAQ:ONTX) last released its quarterly earnings results on Monday, August 15th. The biopharmaceutical company reported ($1.96) earnings per share (EPS) for the quarter. The company earned $2.25 million during the quarter. On average, analysts forecast that Onconova Therapeutics Inc. will post ($7.40) earnings per share for the current year.
Onconova Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways important to cancer cells. It has three clinical-stage product candidates and many preclinical programs that target kinases, cellular metabolism or cell division.